![](https://investorshub.advfn.com/uicon/146420.png?cb=1620496853)
Tuesday, September 07, 2010 6:28:09 PM
I feel compelled to address some of the issues you raised in your post # 56034…
You stated:
“The BOD and mgmt can change the direction and the fortunes of this company in one second if they really wanted to. Again, all it takes is an announcement of a qualified and real COB not one of ES's cronies.”
In my humble view…There is nothing wrong with the direction the company is taking. That is…Advance Bavi anti-cancer ASAP using company money. Advance Bavi anti-viral using external money. Continue moving Cotara along. Continue increasing revenue through addition CMO business, biosimilars development, government grants and contracts. As to the fortunes of this company…THE ONLY THING THAT WILL CHANGE THAT IS ADDITIONAL MONEY…!!! No one individual by virtue of his persona alone can change the fortune of a company…Unless he comes with sacks of money….
You then continue with:
“There is absolutely no harm that can be done in doing so and by not doing so mgmt is showing no matter what Mr. King says that they are not interested in accelerating their drug pipeline or making their company successful.”
How does it logically follow that; because they have not filled the COB position that the company is “not interested in accelerating their drug pipeline or making their company successful.”? They ARE moving the drug pipeline along quite well with the limited resources they have. The success of the company will be determined by the success of the science…Nothing else can make this company successful.
You then add:
“Just think if the stock price was higher or if PPHM was sold how much faster the trials could be started and finished and how many more trials could be done.”
My goal is to have the maximum return on my investment. The only issue with where the current price is; is the issue of additional financing at this level. Selling PPHM today…??? At what price…???
What Sir do you consider a good price…??? I’ve made my calculations…You can read them in my previous FEW posts on this board…If the science holds out, this enterprise WILL be worth billions…Which implies that shares will be worth north of $100.00/per share…That’s what I’m holding for…And You…???
You then jump off the deep end with this beauty:
“Instead they insult shareholders and make the pro mgmt supporters look even more dumber by saying the company is better off without a COB. (How has it gone so far without one?)”
Could you please explain that? For this casual observer, it appears that you just threw something up in the air and are now hoping that it will deify gravity…!!!
You conclude with:
“Seven years and counting and not one person has been replaced on the board given all the mistakes they have made. Really criminal imo.”
I will conclude:
This board…As is the case with most boards with some history, have made mistakes…They also made some pretty good decisions as well. Changing priorities from Cotara to Bavi I consider; being one of them. The entrenchment of the board…!!! Deal with it…It’s a reality…!!! The fact that the COB position has not been filled could very well imply that under the right conditions this position could be filled with an eminently qualified individual replete with several bushels of cash…Or not…We don't know
If you think that the BOD stinks…You need to walk around Wall St. The stench of greed and evil will cause your nose to blow up and your eyeballs to pop out.
Regards
Golfho
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM